Sanofi Hemophilia Investor Event 2022

Sanofi presented its hemophilia business strategy and product pipeline at an investor event in London. The presentation covers forward-looking statements regarding development, regulatory approvals, and commercial potential of hemophilia therapeutics. Risk factors and market uncertainties are disclosed in accordance with securities regulations.